Tatva Chintan Pharma Chem 미래 성장
Future 기준 확인 5/6
Tatva Chintan Pharma Chem is forecast to grow earnings and revenue by 70.5% and 30% per annum respectively. EPS is expected to grow by 70.5% per annum. Return on equity is forecast to be 9.4% in 3 years.
주요 정보
70.5%
수익 성장률
70.5%
EPS 성장률
Chemicals 수익 성장 | 21.0% |
매출 성장률 | 30.0% |
향후 자기자본 수익률 | 9.4% |
애널리스트 커버리지 | Low |
마지막 업데이트 | 28 Oct 2024 |
최근 미래 성장 업데이트
Recent updates
Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Price In Tune With Revenues
Sep 26Tatva Chintan Pharma Chem (NSE:TATVA) Has Affirmed Its Dividend Of ₹2.00
Aug 29Earnings Report: Tatva Chintan Pharma Chem Limited Missed Revenue Estimates By 33%
Jul 27Weak Statutory Earnings May Not Tell The Whole Story For Tatva Chintan Pharma Chem (NSE:TATVA)
May 11Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Share Price Matching Investor Opinion
Apr 04These Analysts Just Made A Notable Downgrade To Their Tatva Chintan Pharma Chem Limited (NSE:TATVA) EPS Forecasts
Jan 26Tatva Chintan Pharma Chem Limited (NSE:TATVA) Analysts Are Reducing Their Forecasts For This Year
May 10Tatva Chintan Pharma Chem Limited Just Missed Revenue By 15%: Here's What Analysts Think Will Happen Next
Jul 28Getting In Cheap On Tatva Chintan Pharma Chem Limited (NSE:TATVA) Is Unlikely
Jun 17Investors Shouldn't Be Too Comfortable With Tatva Chintan Pharma Chem's (NSE:TATVA) Robust Earnings
May 03Are Investors Undervaluing Tatva Chintan Pharma Chem Limited (NSE:TATVA) By 45%?
Dec 06수익 및 매출 성장 예측
날짜 | 수익 | 수익 | 잉여 현금 흐름 | 작전 현금 | 평균 애널리스트 수 |
---|---|---|---|---|---|
3/31/2027 | 7,638 | 931 | -8 | 610 | 2 |
3/31/2026 | 5,807 | 669 | -562 | 633 | 3 |
3/31/2025 | 4,108 | 148 | -131 | 453 | 3 |
9/30/2024 | 3,714 | 176 | -769 | 395 | N/A |
6/30/2024 | 3,846 | 261 | N/A | N/A | N/A |
3/31/2024 | 3,935 | 304 | -305 | 980 | N/A |
12/31/2023 | 4,198 | 377 | N/A | N/A | N/A |
9/30/2023 | 4,562 | 459 | -590 | 1,145 | N/A |
6/30/2023 | 4,496 | 452 | N/A | N/A | N/A |
3/31/2023 | 4,236 | 455 | -1,753 | 278 | N/A |
12/31/2022 | 3,976 | 460 | N/A | N/A | N/A |
9/30/2022 | 3,817 | 572 | -1,480 | -99 | N/A |
6/30/2022 | 4,152 | 825 | N/A | N/A | N/A |
3/31/2022 | 4,336 | 959 | -689 | 202 | N/A |
12/31/2021 | 4,438 | 995 | N/A | N/A | N/A |
9/30/2021 | 4,192 | 976 | N/A | N/A | N/A |
6/30/2021 | 3,557 | 687 | N/A | N/A | N/A |
3/31/2021 | 3,004 | 523 | -13 | 197 | N/A |
3/31/2020 | 2,632 | 378 | -229 | 253 | N/A |
3/31/2019 | 2,063 | 205 | -24 | 74 | N/A |
3/31/2018 | 1,358 | 123 | N/A | 126 | N/A |
애널리스트 미래 성장 예측
수입 대 저축률: TATVA's forecast earnings growth (70.5% per year) is above the savings rate (6.7%).
수익 vs 시장: TATVA's earnings (70.5% per year) are forecast to grow faster than the Indian market (18.1% per year).
고성장 수익: TATVA's earnings are expected to grow significantly over the next 3 years.
수익 대 시장: TATVA's revenue (30% per year) is forecast to grow faster than the Indian market (10.2% per year).
고성장 수익: TATVA's revenue (30% per year) is forecast to grow faster than 20% per year.
주당 순이익 성장 예측
미래 자기자본 수익률
미래 ROE: TATVA's Return on Equity is forecast to be low in 3 years time (9.4%).